Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Gynecologic 2

Conditions

Endometrial Neoplasms 8Endometrial Hyperplasia 4Overweight 2Obesity 2Neoplasms 2Weight Loss 1Menorrhagia 1Leiomyoma 1Infertility 1Hematologic Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Breast Neoplasms 1Breast Cancer Patients Treated With T-DXd 1Anorexia 1

Interventions

Counseling 4Tirzepatide 2Nutrition Assessment 2Methods 2Megestrol Acetate 2Diet Therapy 2semaglutide 1Urine Specimen Collection 1Trehalase 1Tablets 1Resistance Training 1Psychology, Positive 1Progestins 1Patient Navigation 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Exercise 1Estrogen Replacement Therapy 1Educational Status 1Early Intervention, Educational 1Diet, Plant-Based 1Diet, Healthy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Overweight × Megestrol Acetate × 1 year × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡